Nahid Heydari Marandi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nahid Heydari Marandi has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Marzieh Jamalidoust
Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
5 shared publications - Mazyar Ziyaeyan
Department of Clinical Virology, Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Namazi Hospital, Shiraz, Iran
5 shared publications - Nasrin Aliabadi
Department of Clinical Virology, Clinical Microbiology Research Center Shiraz University of Medical Sciences, Namazi Hospital Shiraz Iran
5 shared publications - Gholamreza Pouladfar
Professor Alborzi Clinical Microbiology Research Center, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
4 shared publications - Marzieh Hosseini
Department of Clinical Virology, Clinical Microbiology Research Center, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
2 shared publications Ali Faramarzi
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
1 shared publication
Latest Publications
- Open Access
- 29 November 2024
- Published by Brieflands in Archives of Pediatric Infectious Diseases
- Vol. 13 (2)
Identification of Viral Causes in Cerebrospinal Fluid of Patients Under Investigation for Central Nervous System Infections During the COVID-19 Epidemic: A Cross-Sectional Study
Background: Although viral etiology of central nervous system (CNS) infections such as meningitis and encephalitis are investigated widely worldwide, it remains to be declared under the COVID-19 pandemic. Objectives: The focus of this study was to examine the etiology of viral CNS infections in patients hospitalized in a single referral hospital during the outbreak in Iran. Methods: We retrospectively collected the cerebrospinal fluid (CSF) samples and reviewed the medical records of patients hospitalized with suspected viral CNS infection in Shiraz, a large city in southern Iran, from April 2021 to May 2022. One hundred sixty-six CSF samples were tested primarily for detection of HSV-1 and -2 and retrospectively analyzed by primers polymerase chain reaction (PCR) targeted to coronavirus 2 (SARS-CoV-2), human herpesviruses1 to 6 (HHV-1 to 6), polyomaviruses JC, and enteroviruses (EV). Results: Of the total CSF samples analyzed by PCR, 22 (13.3%) were positive for only one viral pathogen, and just one (0.6%) sample was detected with multiple viruses (HSV-1 and CMV). The SARS-CoV-2 (6 cases) was the second most common viral etiology just after Herpes simplex virus-1 (HSV-1) 6.6% (11 cases). Other detected viruses were CMV for 1.8% (3 cases), VZV for 1.2% (2 cases), and JC for 0.6% (1 case) of the cases. Conclusions: This study highlights the prevalence of viral pathogens in CSF samples from patients with suspected meningitis at Namazi Teaching Hospital. Notably, HSV-1 was the most common virus detected, followed by SARS-CoV-2. These findings underscore the importance of viral testing in the diagnosis and management of meningitis.
- 29 November 2024
- Published by Brieflands in Archives of Pediatric Infectious Diseases
- Vol. 13 (2)
Open AccessIdentification of Viral Causes in Cerebrospinal Fluid of Patients Under Investigation for Central Nervous System Infections During the COVID-19 Epidemic: A Cross-Sectional Study
Background: Although viral etiology of central nervous system (CNS) infections such as meningitis and encephalitis are investigated widely worldwide, it remains to be declared under the COVID-19 pandemic. Objectives: The focus of this study was to examine the etiology of viral CNS infections in patients hospitalized in a single referral hospital during the outbreak in Iran. Methods: We retrospectively collected the cerebrospinal fluid (CSF) samples and reviewed the medical records of patients hospitalized with suspected viral CNS infection in Shiraz, a large city in southern Iran, from April 2021 to May 2022. One hundred sixty-six CSF samples were tested primarily for detection of HSV-1 and -2 and retrospectively analyzed by primers polymerase chain reaction (PCR) targeted to coronavirus 2 (SARS-CoV-2), human herpesviruses1 to 6 (HHV-1 to 6), polyomaviruses JC, and enteroviruses (EV). Results: Of the total CSF samples analyzed by PCR, 22 (13.3%) were positive for only one viral pathogen, and just one (0.6%) sample was detected with multiple viruses (HSV-1 and CMV). The SARS-CoV-2 (6 cases) was the second most common viral etiology just after Herpes simplex virus-1 (HSV-1) 6.6% (11 cases). Other detected viruses were CMV for 1.8% (3 cases), VZV for 1.2% (2 cases), and JC for 0.6% (1 case) of the cases. Conclusions: This study highlights the prevalence of viral pathogens in CSF samples from patients with suspected meningitis at Namazi Teaching Hospital. Notably, HSV-1 was the most common virus detected, followed by SARS-CoV-2. These findings underscore the importance of viral testing in the diagnosis and management of meningitis.
- Open Access
- 29 October 2024
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 17 (10)
Human Papillomavirus Prevalence in Urine and Anatomical Sites in South Iranian Men and Women with Normal and External Genital Warts: A Cross-Sectional Study
Background: Human papillomavirus (HPV) is the most prevalent sexually transmitted infection, especially among sexually active individuals. Objectives: This study aimed to determine the prevalence of HPV infection among males and females in Southern Iran. Although previous studies have explored HPV prevalence in various provinces across Iran, this research is unique as the first to examine a four-type sample within this region. Methods: This cross-sectional study involved a sample of residents from Southern Iran, comprising 82 females (71.9%) and 32 males (28.1%), aged between 13 and 74 years, most of whom were sexually active. The main focus of the research was to investigate HPV infection across various anatomical sites in both healthy women and those with external genital warts (eGW). Results: The anatomical sites assessed included the oral, anal, vaginal, and urinary areas. Out of the total sample, 79 individuals (69.3%) tested positive for HPV. Within this group, 65 individuals (81.3%) were from the eGW group, while 14 individuals (41.2%) belonged to the normal population. A statistically significant difference (P ≤ 0.1) was observed in the prevalence of HPV in oral samples between the two groups. In the eGW group, 61 participants were positive for low-risk HPV (LR-HPV) genotypes, and 4 tested positive for HPV-18. Among the normal population, 14 individuals tested positive for LR-HPV genotypes. Notably, a higher proportion of positive HPV results—approximately 29%—was identified in anal and urinary samples compared to vaginal samples from females in the normal population. Conclusions: Significant differences in HPV prevalence were noted between individuals with eGW and those in the normal population. Overall, the prevalence of HPV among eGW individuals was approximately twice that of the normal population across the four anatomical sites. Further research is warranted to better understand the association between HPV infection, eGW, and various sociodemographic factors.
- 29 October 2024
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 17 (10)
Open AccessHuman Papillomavirus Prevalence in Urine and Anatomical Sites in South Iranian Men and Women with Normal and External Genital Warts: A Cross-Sectional Study
Background: Human papillomavirus (HPV) is the most prevalent sexually transmitted infection, especially among sexually active individuals. Objectives: This study aimed to determine the prevalence of HPV infection among males and females in Southern Iran. Although previous studies have explored HPV prevalence in various provinces across Iran, this research is unique as the first to examine a four-type sample within this region. Methods: This cross-sectional study involved a sample of residents from Southern Iran, comprising 82 females (71.9%) and 32 males (28.1%), aged between 13 and 74 years, most of whom were sexually active. The main focus of the research was to investigate HPV infection across various anatomical sites in both healthy women and those with external genital warts (eGW). Results: The anatomical sites assessed included the oral, anal, vaginal, and urinary areas. Out of the total sample, 79 individuals (69.3%) tested positive for HPV. Within this group, 65 individuals (81.3%) were from the eGW group, while 14 individuals (41.2%) belonged to the normal population. A statistically significant difference (P ≤ 0.1) was observed in the prevalence of HPV in oral samples between the two groups. In the eGW group, 61 participants were positive for low-risk HPV (LR-HPV) genotypes, and 4 tested positive for HPV-18. Among the normal population, 14 individuals tested positive for LR-HPV genotypes. Notably, a higher proportion of positive HPV results—approximately 29%—was identified in anal and urinary samples compared to vaginal samples from females in the normal population. Conclusions: Significant differences in HPV prevalence were noted between individuals with eGW and those in the normal population. Overall, the prevalence of HPV among eGW individuals was approximately twice that of the normal population across the four anatomical sites. Further research is warranted to better understand the association between HPV infection, eGW, and various sociodemographic factors.
- Open Access
- 27 October 2024
- Published by Brieflands in Archives of Pediatric Infectious Diseases
- Vol. 13 (1)
Etiology of Severe Acute Respiratory Infections in ICU-Admitted Patients During the COVID-19 Pandemic in Iran: A Single Center Study
Background: Acute respiratory infections (ARI) caused by a wide range of etiologies represent a significant public health challenge worldwide. Objectives: In this study, we aimed to evaluate the characteristics of ARI caused by various respiratory pathogens among patients admitted to intensive care units (ICUs) in a referral hospital in Iran during the first four waves of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Methods: A total of 395 patients with ARI were enrolled, all hospitalized in the ICUs of Nemazi Teaching Hospital, affiliated with Shiraz University of Medical Sciences in Shiraz, Iran, over a 13-month period from April 2020 to June 2021. Real-time polymerase chain reaction (RT-PCR) assays were used to detect SARS-CoV-2, influenza viruses, respiratory syncytial virus (RSV), Mycoplasma, and Chlamydia in nasopharyngeal fluid (NPS) samples. The demographic and clinical data, including underlying diseases, were also considered. Results: Of the 395 patients, 209 (53.7%) were male, and the mean age was 32 ± 27 years. An etiology was detected in 63 (16%) patients, with 53 testing positive for SARS-CoV-2 and 5 each for Chlamydia and Mycoplasma. No RSV or influenza infections were detected. The highest rate of COVID-19 was observed among adults aged 36 to 65 years (5.31%), while the lowest rate was in children under 5 years old (0.3%). Shortness of breath was the most common symptom in SARS-CoV-2-infected patients (P-value ≤ 0.001). Of the total patients, 146 (37%) had at least one underlying disease, with diabetes being the most common (8.1%). Conclusions: The absence of RSV and influenza infections, along with a notable number of Chlamydia and Mycoplasma infections during the first four waves of the SARS-CoV-2 pandemic, emphasizes the importance of continuous surveillance of the etiologies of ARI during respiratory pandemics. This information is critical for guiding appropriate infection control measures and selecting empirical antibiotic regimens.
- 27 October 2024
- Published by Brieflands in Archives of Pediatric Infectious Diseases
- Vol. 13 (1)
Open AccessEtiology of Severe Acute Respiratory Infections in ICU-Admitted Patients During the COVID-19 Pandemic in Iran: A Single Center Study
Background: Acute respiratory infections (ARI) caused by a wide range of etiologies represent a significant public health challenge worldwide. Objectives: In this study, we aimed to evaluate the characteristics of ARI caused by various respiratory pathogens among patients admitted to intensive care units (ICUs) in a referral hospital in Iran during the first four waves of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Methods: A total of 395 patients with ARI were enrolled, all hospitalized in the ICUs of Nemazi Teaching Hospital, affiliated with Shiraz University of Medical Sciences in Shiraz, Iran, over a 13-month period from April 2020 to June 2021. Real-time polymerase chain reaction (RT-PCR) assays were used to detect SARS-CoV-2, influenza viruses, respiratory syncytial virus (RSV), Mycoplasma, and Chlamydia in nasopharyngeal fluid (NPS) samples. The demographic and clinical data, including underlying diseases, were also considered. Results: Of the 395 patients, 209 (53.7%) were male, and the mean age was 32 ± 27 years. An etiology was detected in 63 (16%) patients, with 53 testing positive for SARS-CoV-2 and 5 each for Chlamydia and Mycoplasma. No RSV or influenza infections were detected. The highest rate of COVID-19 was observed among adults aged 36 to 65 years (5.31%), while the lowest rate was in children under 5 years old (0.3%). Shortness of breath was the most common symptom in SARS-CoV-2-infected patients (P-value ≤ 0.001). Of the total patients, 146 (37%) had at least one underlying disease, with diabetes being the most common (8.1%). Conclusions: The absence of RSV and influenza infections, along with a notable number of Chlamydia and Mycoplasma infections during the first four waves of the SARS-CoV-2 pandemic, emphasizes the importance of continuous surveillance of the etiologies of ARI during respiratory pandemics. This information is critical for guiding appropriate infection control measures and selecting empirical antibiotic regimens.
- Open Access
- 23 August 2022
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 15 (7)
Seroprevalence of Anti-SARS-CoV-2 Antibodies in High-Risk Occupational and Low-Risk Groups in Southwestern Iran
Background: Monitoring the spread of SARS-CoV-2 has been considered by the World Health Organization (WHO). We examined the prevalence of anti-SARS-CoV-2 immunoglobulin antibodies in southwestern Iran in spring 2020. The circulation of SARS-CoV-2 is high in the general population, especially among health care workers (HCWs) who are in close contact with patients. Objectives: The aim of this study was to determine the prevalence of anti-SARS-CoV-2 antigen in high-risk occupational and low-risk groups to investigate risk factors for serum positivity in Shiraz, southwestern Iran. Methods: A cross-sectional survey was performed on 366 participants (204 from high-risk and 162 from low-risk subjects). IgG and IgM antibodies were detected using Pishtaz Teb COVID-19 ELISA Kits to evaluate SARS-CoV-2-antigen in serum samples. After enzyme-linked immunosorbent assay (ELISA), serum prevalence, as well as IgG/IgM positive factors, was determined using logistic regression. Results: From July to September 2020 (a few months after reporting the first case of COVID-19 cases in Iran), out of 366 survived people, 72 (40.9%) were IgG positive, and 50 (27.5%) were IgM positive. The frequency of positive serology for IgG and IgM antibodies in individuals aged < 30 years was higher in the low-risk group than in the high-risk group. Multivariate logistic regression showed that headache (OR 0.312 [95% CI: 0.136 - 0.717]) and cough (OR 0.427 [95% CI: 0.182 - 1.004]) factors were associated with IgG or IgM positive serology. Conclusions: Between July and September 2020, the prevalence of anti-SARS-CoV-2 antigen was high in Shiraz. The prevalence of SARS-CoV-2 IgG/IgM antibodies in the high-risk group and their family as low risk was shown to increase viral infection due to close contact with COVID 19 patients than in the general population. Several factors were found to be related to the prevalence of anti-SARS-CoV-2 antigen that needs to be considered by policymakers to determine what to do about the SARS-CoV-2 pandemic.
- 23 August 2022
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 15 (7)
Open AccessSeroprevalence of Anti-SARS-CoV-2 Antibodies in High-Risk Occupational and Low-Risk Groups in Southwestern Iran
Background: Monitoring the spread of SARS-CoV-2 has been considered by the World Health Organization (WHO). We examined the prevalence of anti-SARS-CoV-2 immunoglobulin antibodies in southwestern Iran in spring 2020. The circulation of SARS-CoV-2 is high in the general population, especially among health care workers (HCWs) who are in close contact with patients. Objectives: The aim of this study was to determine the prevalence of anti-SARS-CoV-2 antigen in high-risk occupational and low-risk groups to investigate risk factors for serum positivity in Shiraz, southwestern Iran. Methods: A cross-sectional survey was performed on 366 participants (204 from high-risk and 162 from low-risk subjects). IgG and IgM antibodies were detected using Pishtaz Teb COVID-19 ELISA Kits to evaluate SARS-CoV-2-antigen in serum samples. After enzyme-linked immunosorbent assay (ELISA), serum prevalence, as well as IgG/IgM positive factors, was determined using logistic regression. Results: From July to September 2020 (a few months after reporting the first case of COVID-19 cases in Iran), out of 366 survived people, 72 (40.9%) were IgG positive, and 50 (27.5%) were IgM positive. The frequency of positive serology for IgG and IgM antibodies in individuals aged < 30 years was higher in the low-risk group than in the high-risk group. Multivariate logistic regression showed that headache (OR 0.312 [95% CI: 0.136 - 0.717]) and cough (OR 0.427 [95% CI: 0.182 - 1.004]) factors were associated with IgG or IgM positive serology. Conclusions: Between July and September 2020, the prevalence of anti-SARS-CoV-2 antigen was high in Shiraz. The prevalence of SARS-CoV-2 IgG/IgM antibodies in the high-risk group and their family as low risk was shown to increase viral infection due to close contact with COVID 19 patients than in the general population. Several factors were found to be related to the prevalence of anti-SARS-CoV-2 antigen that needs to be considered by policymakers to determine what to do about the SARS-CoV-2 pandemic.
- 9 September 2020
- Published by Wiley in Microbiology and Immunology
- Vol. 64 (11) , 762-767
Hepatitis C virus genotypes in patients with chronic hepatitis C infection in southern Iran from 2016 to 2019
Hepatitis C is a liver disease caused by the hepatitis C virus (HCV). The treatment of HCV infection has become more complicated due to various genotypes and subtypes of HCV. The treatment of HCV has made significant advances with direct‐acting antivirals. However, for the choice of medicine or the combination of drugs for hepatitis C, it is imperative to detect and discriminate the crucial HCV genotypes. The main objective of this study was to determine the pattern of circulating HCV genotypes in southern Iran, from 2016 until 2019. The other aim of the study was to determine possible associations of patients’ risk factors with HCV genotypes. A total of 803 serum samples were collected in 4 years (2016–2019) from patients with HCV antibody positive results. A total of 728 serum samples were HCV‐RNA positive. The prevalence of HCV genotypes was detected using the genotype‐specific RT‐PCR test for serum samples obtained from 615 patients. The HCV genotype 1 (G1) was the most prevalent (48.8%) genotype in the area, with G1a, G1b, and mixed G1a/b representing 38.4%, 10.1%, and 0.3%, respectively. Genotype 3a was the next most prevalent (47.2%). Mixed genotypes 1a/3a were detected in 22 (3.6%) and finally G4 was found in 3 (0.5%) patients. The other HCV genotypes were not detected in any patient. Genotype 1 (1a and 1b alone, 1a/1b and 1a/3a coinfections) is the most prevalent HCV genotype in southern Iran. HCV G1 shows a significantly higher rate in people under 40 years old.
- 9 September 2020
- Published by Wiley in Microbiology and Immunology
- Vol. 64 (11) , 762-767
Hepatitis C virus genotypes in patients with chronic hepatitis C infection in southern Iran from 2016 to 2019
Hepatitis C is a liver disease caused by the hepatitis C virus (HCV). The treatment of HCV infection has become more complicated due to various genotypes and subtypes of HCV. The treatment of HCV has made significant advances with direct‐acting antivirals. However, for the choice of medicine or the combination of drugs for hepatitis C, it is imperative to detect and discriminate the crucial HCV genotypes. The main objective of this study was to determine the pattern of circulating HCV genotypes in southern Iran, from 2016 until 2019. The other aim of the study was to determine possible associations of patients’ risk factors with HCV genotypes. A total of 803 serum samples were collected in 4 years (2016–2019) from patients with HCV antibody positive results. A total of 728 serum samples were HCV‐RNA positive. The prevalence of HCV genotypes was detected using the genotype‐specific RT‐PCR test for serum samples obtained from 615 patients. The HCV genotype 1 (G1) was the most prevalent (48.8%) genotype in the area, with G1a, G1b, and mixed G1a/b representing 38.4%, 10.1%, and 0.3%, respectively. Genotype 3a was the next most prevalent (47.2%). Mixed genotypes 1a/3a were detected in 22 (3.6%) and finally G4 was found in 3 (0.5%) patients. The other HCV genotypes were not detected in any patient. Genotype 1 (1a and 1b alone, 1a/1b and 1a/3a coinfections) is the most prevalent HCV genotype in southern Iran. HCV G1 shows a significantly higher rate in people under 40 years old.